Pfizer, Wyeth Merger May Test Obama FTC's Mettle

Law360, New York (January 23, 2009, 12:00 AM EST) -- The news Friday that pharmaceutical bigwigs Pfizer Inc. and Wyeth Inc. are negotiating a buyout worth more than $60 billion sparked questions of how the Obama administration might respond to such a large proposal, particularly if it has to reconcile anti-competitive overlaps with serious economic troubles in the industry.

Pfizer has been in talks with rival Wyeth for several months about a takeover deal that would unite two of the biggest global drugmakers, the Wall Street Journal reported Friday, citing unnamed sources familiar with the matter....
To view the full article, register now.